1. Home
  2. HSPO vs STIM Comparison

HSPO vs STIM Comparison

Compare HSPO & STIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HSPO
  • STIM
  • Stock Information
  • Founded
  • HSPO 2014
  • STIM 2003
  • Country
  • HSPO United States
  • STIM United States
  • Employees
  • HSPO N/A
  • STIM N/A
  • Industry
  • HSPO Blank Checks
  • STIM Medical/Dental Instruments
  • Sector
  • HSPO Finance
  • STIM Health Care
  • Exchange
  • HSPO Nasdaq
  • STIM Nasdaq
  • Market Cap
  • HSPO 92.0M
  • STIM 192.0M
  • IPO Year
  • HSPO 2022
  • STIM 2018
  • Fundamental
  • Price
  • HSPO $11.70
  • STIM $4.36
  • Analyst Decision
  • HSPO
  • STIM Buy
  • Analyst Count
  • HSPO 0
  • STIM 4
  • Target Price
  • HSPO N/A
  • STIM $4.67
  • AVG Volume (30 Days)
  • HSPO 3.5K
  • STIM 1.7M
  • Earning Date
  • HSPO 01-01-0001
  • STIM 03-04-2025
  • Dividend Yield
  • HSPO N/A
  • STIM N/A
  • EPS Growth
  • HSPO 2.63
  • STIM N/A
  • EPS
  • HSPO 0.28
  • STIM N/A
  • Revenue
  • HSPO N/A
  • STIM $72,711,000.00
  • Revenue This Year
  • HSPO N/A
  • STIM $3.23
  • Revenue Next Year
  • HSPO N/A
  • STIM $29.55
  • P/E Ratio
  • HSPO $41.53
  • STIM N/A
  • Revenue Growth
  • HSPO N/A
  • STIM 5.03
  • 52 Week Low
  • HSPO $10.80
  • STIM $0.52
  • 52 Week High
  • HSPO $12.41
  • STIM $5.07
  • Technical
  • Relative Strength Index (RSI)
  • HSPO 52.06
  • STIM 73.44
  • Support Level
  • HSPO $11.70
  • STIM $2.80
  • Resistance Level
  • HSPO $11.89
  • STIM $3.65
  • Average True Range (ATR)
  • HSPO 0.10
  • STIM 0.47
  • MACD
  • HSPO -0.01
  • STIM 0.06
  • Stochastic Oscillator
  • HSPO 18.37
  • STIM 89.01

About HSPO Horizon Space Acquisition I Corp.

Horizon Space Acquisition I Corp is a blank check company.

About STIM Neuronetics Inc.

Neuronetics Inc a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulations, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advanced Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address many of the key limitations of existing treatment options.

Share on Social Networks: